Back

Thomasclavelia ramosa is a Signature of Gut Dysbiosis associated with Alcohol-Related Hepatocellular Carcinoma: A First Microbial Culturomics Study

Magdy Wasfy, R.; ABDOULAYE, A.; BORENTAIN, P.; MBAYE, B.; TIDJANI ALOU, M.; CAPUTO, A.; ANDRIEU, C.; MOTTOLA, G.; LEVASSEUR, A.; Million, M.; GEROLAMI, R.

2024-08-20 gastroenterology
10.1101/2024.08.19.24312231 medRxiv
Show abstract

BackgroundGut microbiota alteration is implicated in the pathogenesis of alcoholic liver disease (ALD) and HCC. No study has characterized the dysbiosis associated with ALD by microbial culturomics, an approach that certifies viability and allows the characterization of pathobiont strain candidates. MethodsA case-control study was conducted on patients with ALD without HCC (ALD-NoHCC) (n=16), ALD with HCC (ALD-HCC) (n=19), and controls (n=24). 16S rRNA amplicon sequencing and microbial culturomics were used as complementary methods for gut microbiome profiling. ResultsBy microbial culturomics, Thomasclavelia ramosa was the most enriched and detected in all ALD samples (100%), while it was cultivated in only a small proportion of controls (20%, p < 0.001). By 16S rRNA amplicon sequencing and 3-groups linear discriminant analysis, T. ramosa was increased explicitly in the ALD-HCC group (LDA-score > 5, p < 0.05). ConclusionsT. ramosa, identified by culturomics and 16 rRNA sequencing, is associated with ALD and ALD-HCC. Alongside the recently reported in vitro genotoxicity of this species in colorectal cancer, this species has been identified as a candidate oncobiont in ALD-HCC. HighlightsO_LIThe gut microbiota signature of ALD and ALD-HCC was explored by microbial culturomics and 16S amplicon sequencing C_LIO_LIBy culturomics, T. ramosa was the most enriched and cultured from all included ALD patients, but in only 20% of controls (p < 0.05). C_LIO_LIT. ramosa was significantly associated with alcohol-related HCC by 16S sequencing. C_LIO_LIT. ramosa is identified as a putative oncobiont associated with ALD-HCC, thus opening new avenues for diagnosis and treatment. C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/24312231v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@7db628org.highwire.dtl.DTLVardef@1420dc8org.highwire.dtl.DTLVardef@196fc7borg.highwire.dtl.DTLVardef@19a0ed4_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Metabolomics
11 papers in training set
Top 0.1%
10.5%
2
Scientific Reports
3102 papers in training set
Top 8%
8.7%
3
Environmental Research
46 papers in training set
Top 0.1%
8.7%
4
Gut Microbes
70 papers in training set
Top 0.1%
6.6%
5
Microbiology Spectrum
435 papers in training set
Top 0.4%
4.5%
6
mSystems
361 papers in training set
Top 3%
3.7%
7
Frontiers in Microbiology
375 papers in training set
Top 2%
3.7%
8
Biomedicines
66 papers in training set
Top 0.3%
2.8%
9
PLOS ONE
4510 papers in training set
Top 47%
2.2%
50% of probability mass above
10
BMC Medicine
163 papers in training set
Top 2%
2.2%
11
Heliyon
146 papers in training set
Top 0.9%
2.2%
12
Environment International
42 papers in training set
Top 0.6%
2.2%
13
Frontiers in Oncology
95 papers in training set
Top 2%
1.9%
14
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 2%
1.9%
15
eBioMedicine
130 papers in training set
Top 1%
1.7%
16
eLife
5422 papers in training set
Top 44%
1.5%
17
PeerJ
261 papers in training set
Top 8%
1.5%
18
Toxicological Sciences
38 papers in training set
Top 0.3%
1.5%
19
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 5%
1.4%
20
Water Research
74 papers in training set
Top 1%
1.3%
21
Genes
126 papers in training set
Top 2%
1.2%
22
Nature Communications
4913 papers in training set
Top 57%
1.2%
23
Contemporary Clinical Trials Communications
11 papers in training set
Top 0.4%
1.0%
24
Gastroenterology
40 papers in training set
Top 2%
0.8%
25
Science of The Total Environment
179 papers in training set
Top 4%
0.8%
26
Bioengineering & Translational Medicine
21 papers in training set
Top 0.7%
0.8%
27
Metabolites
50 papers in training set
Top 1%
0.8%
28
Cancers
200 papers in training set
Top 5%
0.8%
29
Frontiers in Medicine
113 papers in training set
Top 6%
0.8%
30
Frontiers in Nutrition
23 papers in training set
Top 1%
0.7%